Kirkland Suffers Swift Defeat in Teva FDA Fight

Less than a week after Teva Pharmaceutical Industries sued the FDA to block competitors from marketing generic versions of its blockbuster multiple sclerosis drug Copaxone, the company's lawyers are back where they started.

Sign up for a free Law.com trial now!

Law.com's Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on Law.com
  • The free Law.com InPractice digital newsletter
  • Personalized legal news on the Law.com mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Law.com Newswire digital newsletter.